Notice Regarding Differences Between Consolidated Forecasts and Actual Results for the Second Quarter (Interim) of the Fiscal Year Ending March 2027 and Revision of Full-Year Consolidated Forecasts

Overview of Forecast Revision

We reviewed the differences between the consolidated forecasts and actual results for the second quarter of the fiscal year ending March 2027 and upwardly revised the full-year forecasts. Net sales are expected to exceed the previous forecast, and operating income, ordinary income, net income attributable to owners of parent, and earnings per share are all expected to increase significantly. The primary factors are strong demand in the industrial equipment market (including semiconductor manufacturing equipment and FA equipment) and the medical device market; despite the impact of rising raw material costs, expanded sales and production efficiency improvements have contributed. Sales in overseas markets are also expected to remain solid from the third quarter onward, prompting the revision of the full-year forecast.

Outlook and Points to Note

We will continue order acquisition activities focused on priority markets and aim to improve profitability even in an environment of continued raw material cost increases. Please note that actual results may differ materially from forecasts due to external factors.